Literature DB >> 1002301

Lung weight parallels disease severity in experimental coccidioidomycosis.

M Huppert, S H Sun, I Gleason-Jordon, K R Vukovich.   

Abstract

Evidence provided by histopathological study of lesions is a valuable adjunct for evaluating chemotherapeutic efficacy in experimental animal models, In addition, this should be correlated with a measure of disease severity in the same animal. The latter could be obtained by homogenization of infected organs and quantitative enumeration of viable cells of the etiological agent, but this would preclude histopathological studies in the same animal. Progression of disease in pulmonary infection is associated with replacement of air space by fluid, cells, and cellular debris. Therefore, an increase in lung weight should reflect severity of disease. Results with the murine model of coccidioidomycosis demonstrate that increasing lung weight parallels the increasing census of fungus cells in the lungs of both treated and nontreated infected mice. This was supported with evidence obtained from microscopic studies of lesions indicating that specific chemotherapy limited spread of the infection and inhibited multiplication of the fungus in the lung. Therefore, lung weight can be used as a measure of disease severity in the murine model of coccidioidomycosis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1002301      PMCID: PMC415539          DOI: 10.1128/iai.14.6.1356-1368.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  AN ACUTE PULMONARY GRANULOMATOUS RESPONSE IN MICE PRODUCED BY MYCOBACTERIAL CELLS AND ITS RELATION TO INCREASED RESISTANCE AND INCREASED SUSCEPTIBILITY TO EXPERIMENTAL TUBERCULOUS INFECTION.

Authors:  G P YOUMANS; A S YOUMANS
Journal:  J Infect Dis       Date:  1964-04       Impact factor: 5.226

2.  COCCIDIOIDOMYCOSIS: STUDIES OF CANINE VACCINATION AND THERAPY.

Authors:  M W CASTLEBERRY; J L CONVERSE; J T SINSKI; E P LOWE; S P PAKES; J E DELFAVERO
Journal:  J Infect Dis       Date:  1965-02       Impact factor: 5.226

3.  Response of monkeys to respiratory challenge following subcutaneous inoculation with Coccidioides immitis.

Authors:  D PAPPAGIANIS; R L MILLER; C E SMITH; G S KOBAYASHI
Journal:  Am Rev Respir Dis       Date:  1960-08

4.  Experimental coccidioidomycosis in dogs.

Authors:  P G HUGENHOLTZ; R E REED; K T MADDY; R J TRAUTMAN; J D BARGER
Journal:  Am J Vet Res       Date:  1958-04       Impact factor: 1.156

5.  Studies on Coccidioides immitis: morphology and sporulation capacity of forty-seven strains.

Authors:  L FRIEDMAN; D PAPAGIANIS; R J BERMAN; C E SMITH
Journal:  J Lab Clin Med       Date:  1953-09

6.  Influence of vaccination on respiratory coccidiodial disease in cynomolgous monkeys.

Authors:  H B LEVINE; R L MILLER; C E SMITH
Journal:  J Immunol       Date:  1962-08       Impact factor: 5.422

7.  Changes in murine resistance to Listeria monocytogenes infection induced by amphotericin B.

Authors:  M Z Thomas; G Medoff; G S Kobayashi
Journal:  J Infect Dis       Date:  1973-04       Impact factor: 5.226

8.  Immunity development in mice RECEIVING KILLED Coccidioides immitis spherules: effect of removing residual vaccine.

Authors:  H B Levine; Y M Kong
Journal:  Sabouraudia       Date:  1965-10

9.  Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).

Authors:  G Medoff; G S Kobayashi; C N Kwan; D Schlessinger; P Venkov
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

10.  Potentiation of the antifungal effects of antibiotics by amphotericin B.

Authors:  C N Kwan; G Medoff; G S Kobayashi; D Schlessinger; H J Raskas
Journal:  Antimicrob Agents Chemother       Date:  1972-08       Impact factor: 5.191

View more
  6 in total

Review 1.  Murine models of blastomycosis, coccidioidomycosis, and histoplasmosis.

Authors:  K N Sorensen; K V Clemons; D A Stevens
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

2.  Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia.

Authors:  P D Walzer; R D Powell; K Yoneda; M E Rutledge; J E Milder
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

3.  Mouse Model of a Human STAT4 Point Mutation That Predisposes to Disseminated Coccidiomycosis.

Authors:  Daniel A Powell; Amy P Hsu; Lisa F Shubitz; Christine D Butkiewicz; Hilary Moale; Hien T Trinh; Thomas Doetschman; Teodora G Georgieva; Dakota M Reinartz; Justin E Wilson; Marc J Orbach; Steven M Holland; John N Galgiani; Jeffrey A Frelinger
Journal:  Immunohorizons       Date:  2022-02-11

4.  Comparison of histologic and quantitative techniques in evaluation of therapy for experimental Pneumocystis carinii pneumonia.

Authors:  C K Kim; J M Foy; M T Cushion; D Stanforth; M J Linke; H L Hendrix; P D Walzer
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

5.  Differences in innate immune responses correlate with differences in murine susceptibility to Chlamydia muridarum pulmonary infection.

Authors:  Xiaozhou Jiang; Caixia Shen; Hong Yu; Karuna P Karunakaran; Robert C Brunham
Journal:  Immunology       Date:  2009-09-11       Impact factor: 7.397

6.  Protective antigens against glanders identified by expression library immunization.

Authors:  Gregory C Whitlock; Mark D Robida; Barbara M Judy; Omar Qazi; Katherine A Brown; Arpaporn Deeraksa; Katherine Taylor; Shane Massey; Andrey Loskutov; Alex Y Borovkov; Kevin Brown; Jose A Cano; Alfredo G Torres; D Mark Estes; Kathryn F Sykes
Journal:  Front Microbiol       Date:  2011-11-21       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.